Tata Consumer Q1: consolidated PAT +29% to ₹427 Cr on margin expansion, beats Street
PAT +28.8% YoY · revenue +11.9% · margins expanding · beat vs street
₹5,348.88 Cr
+11.9% YoY
₹427.19 Cr
+28.8% YoY
7.88%
+1pp YoY
₹4.31
Tata Consumer Products delivered a clean, margin-led Q1 FY27. Consolidated revenue of ₹5,348.88 Cr grew 11.9% YoY (12% reported, 9% constant currency) but slipped 1.6% sequentially off the seasonally stronger March quarter. Group consolidated net profit rose 28.8% YoY to ₹427.19 Cr, essentially flat versus ₹424.02 Cr in Q4. With profit growing more than twice as fast as revenue, the story is margin expansion, not topline — consolidated net margin widened to 7.99% from 6.94% a year ago and operating margin to 10.56% from 9.76%.
Q1 FY-2027 vs prior quarters
The margin bridge sits on India tea costs, which management said tapered through the quarter and lifted branded-business profitability, partly offset by elevated US coffee costs, input inflation and higher brand investment. Segment detail shows India branded revenue +13% and International +5%, while the Non-Branded plantation/extraction business fell 10%. PBT before exceptional items was ₹592 Cr, +27% YoY; there were no exceptional items this quarter or in the year-ago base, so reported and adjusted growth are identical — no one-off is flattering the print.
The stock went into the print at ₹1,092, down 0.6% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters.
Management provides confident guidance for double-digit revenue growth, with EBITDA expected to grow ahead of the top line. They are committed to delivering 50-75 basis points of EBITDA margin expansion in FY27, supported by benign tea costs and improving coffee margins. This will be driven by strategic execution of th
— This quarter: met
The result beats the Street, which had penciled in roughly ₹416 Cr net profit (+20–25% YoY) on ~12% revenue (Business Standard, Zeebiz previews): revenue landed in line but profit came in ahead. It also tracks management's own FY27 guidance from the Q4 concall — double-digit revenue growth plus 50–75 bps of EBITDA margin expansion on benign tea and improving coffee margins; revenue +12% and ~80 bps of YoY operating-margin expansion put the company on course this quarter. The board cleared the result alongside a run of ESG rating affirmations this month (SES 69.4/100, CRISIL 67 'Strong'); a subsidiary was struck off in June.
W1
Whether benign India tea costs sustain the margin tailwind that lifted OPM ~80 bps YoY to 10.56% and keeps FY27 50–75 bps EBITDA expansion guidance on track
W2
US coffee cost inflation and its drag on International/Non-Branded margins — Non-Branded revenue already −10% YoY
W3
Scale-up of Capital Foods and Organic India acquisitions and India volume trajectory into Q2 FY27
Clean digital PDF (limited-review, unaudited). Consolidated PAT 427.19 Cr is Group Consolidated Net Profit = PAT-after-tax 444.86 less share of associates/JV loss (17.67); minority interest 0.21. No exceptional items in Q1FY27 or in year-ago base, so reported=adjusted. Standalone other income (427.14 Cr) large — subsidiary dividends — inflating standalone PBT above consolidated.
Guidance delivered, but tea inflation higher than expected
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade A
Hit double-digit growth guidance (11.9%), margin expansion 70 bps (within 50-75 bps range), consistent messaging, no guidance withdrawal
Optimistic
next 1–2 quarters
Optimistic
multi-year
Management delivered on double-digit revenue and margin expansion guidance through Q1. Growth businesses firing at 47% with credible 25-30% medium-term aspiration. However, commodity inflation (tea 7-10% vs expected benign, salt, spices dynamic) forces near-term margin caution despite pricing action. No upside surprise to justify buy; execution risk on growth normalization.
₹5348.9 Cr
Revenue · +11.9% YoY₹427.2 Cr
Reported PAT · +28.8% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Consolidated revenue grew 12% with strong growth businesses
METRevenue ₹5,348.9 Cr, +11.9% YoY, growth businesses +47%
PAT up 29% on EBITDA growth of 19%, margins expanded 70 bps
METPAT +28.8% to ₹427.2 Cr, EBITDA margin 13.6% (vs 12.9% prior year)
Prior guidance for 50-75 bps margin expansion on track
METDelivered 70 bps expansion in Q1, reaffirming guidance for FY27
Tea volume growth positive despite hot summer and LPG shortage
METTea volumes +2%, but revenue -4% as benefits passed to consumers
Capital Foods/Organic India inflection point reached, 25-30% growth norm
PartialCombined growth 35% this quarter; management cautious (early days), targets 25-30% medium-term
Earnings quality
What changed since the last call
Growth business scale
UpgradeNow 36% of India business, growing 47%, vs prior quarter's lower base. 25-30% medium-term growth norm reaffirmed with credible execution evidence.
Tea inflation outlook
DowngradePrior call implied 'benign tea costs', Q1 saw 7-10% inflation. Management sees peak cropping season just starting, planning for same 7-10% cost trajectory, will take pricing.
Sampann margin trajectory
UpgradeCore portfolio at 30% growth, margin now 12% (up 150-200 bps this quarter) vs -5% in 2020. New launches (dry fruits, cold-pressed oil) adding growth and margin upside.
Capital Foods inflection
UpgradeNow in 'early days' of recovery with green shoots visible (40% growth, innovation + A&P + execution working). Go-to-market structure coming into place, targeting 25-30% norm.
Starbucks maturation
Neutral11% reported growth (+7% CC), mid-single digit same-store sales vs prior year soft base. Guidance for high single-digit top-line going forward (moderating from prior exceptional growth).
The Q&A
Analysts pressed hard on growth business sustainability, margin drivers amid inflation, Capital Foods recovery credibility, and Sampann acceleration. Management responded with specific breakdowns (core ~30%, new categories adding), acknowledged inflation timing lag but defended pricing discipline, provided margin driver clarity (mix shift, operating leverage, Sampann progression). No defensive tone, transparent on uncertainty (tea forecasting).
Growth business capex & inflation — Abneesh Roy, Nuvama
AnsweredMost growth businesses in-house or dedicated co-packers, capex not heavy. Inflation will be passed through with possible time lag. Sampann/growth categories improved margins this quarter despite inflation.
Capital Foods/Organic India recovery — Abneesh Roy, Nuvama
PartialEarly days, taking one quarter at a time. Innovation, A&P, execution starting to work. Go-to-market restructure (Feb relayout) still filling vacancies. Target 25-30% should be norm, not 35%.
Sampann growth drivers — Vivek M., Jefferies
AnsweredCore (pulses, spices, poha) growing ~30% as guided. Dry fruits and cold-pressed oil added to that growth. Overall portfolio very happy.
Salt growth outlook — Vivek M., Jefferies
AnsweredGuidance remains mid-to-high single digits (5-7%). Price hikes take a quarter to settle. Touching 39% share, ambition to cross 40% quickly.
Tea procurement & pricing — Mihir Shah, Nomura
PartialSeeing 7-10% inflation currently, planning for same. Peak cropping just started. Not calling a trend yet, will wait 15-30 days. Minor price increases taken in June, will take judicious pricing to maintain margins.
Overall revenue growth sustainability — Mihir Shah, Nomura
AnsweredWill maintain double digit growth. Growth businesses have long runways (Sampann, RTD). Base comps don't matter as much because category-driven growth in tea/salt, runway in growth businesses.
EBITDA margin guide vs sequential decline — Mihir Shah, Nomura
AnsweredGuided 50-70 bps expansion for year, delivered 70 bps YoY. Seasonality matters (tea peaks Q3/Q4, some businesses Q2/Q3 for festive). Compare to same quarter last year, not sequential. On track for 50-70 bps FY27.
Margin divergence: India vs International — Vivek M., Jefferies
AnsweredIndia: inflation + A&P step-up + FX losses. International: US margin improving as coffee prices normalize. Different drivers, not divergence concern.
Tea share and portfolio health — Percy Panthaki, IIFL
PartialStopped Nielsen disclosure (56% general trade, 16% modern trade, 1 major player doesn't share). From internal data, gained share. Mass premium & premium outperformed bottom end.
Water business outlook — Manoj Menon, ICICI Securities
AnsweredRTD (incl. water) grew 35% volume, 41% revenue. Water in line. Underestimated growth in some regions. Adding capacity next season, possibly early. Doubling down on execution.
17-20% margin aspiration drivers — Manoj Menon, ICICI Securities
AnsweredMix shift to higher-margin Capital Foods/Organic India; water margin improvement with utilization; premium RTD; Sampann margin expansion (now 12%, was -5% in 2020); operating leverage (headcount stable). Scale leverage expected.
Tata Soulfull growth — Anurag Dayal, PhillipCapital
AnsweredGrew 45% this quarter. Significant launches coming in premium. Protein muesli launched, strong response. Muesli top category. Expansion into more categories next 3-6 months.
Pulse inflation risk from El Niño — Bharat Sheth, Quest Investment
AnsweredIf sowing low, prices up, we take pricing. Sampann pulses ₹600-700 Cr vs ₹2.2L Cr pulses market (6% branded). Small share, room to grow. Ball in our court. For tea, if El Niño impact, will take pricing.
Guidance
Double-digit revenue growth FY27 (reiterated)
HighQ1 delivered 11.9%, management sees multiple growth drivers (growth businesses 30%+ long runway, Starbucks SSS + store openings, innovation pipeline). Will see quarters mid-teens and low double digits depending on comps.
50-70 bps EBITDA margin expansion FY27 (maintained)
HighQ1 delivered 70 bps expansion. Drivers: pricing actions on tea/salt (7-10% inflation seen), US coffee margin benefit as prices normalize, cost saving programs, operating leverage from stable headcount.
India food business medium-term: 17-20% EBITDA margin (medium-term aspiration)
MediumFrom current 13.5-14%. Drivers: mix shift to higher-margin growth businesses (Capital Foods/Organic India 50% gross margin), Sampann margin progression (12% now, improving), water utilization, operating leverage as business scales.
Growth business capex not heavy, will evaluate consolidation where scale allows
MediumMost already in-house or dedicated co-packers. Will assess capex case for categories scaling (Sampann initially, water capacity additions). No major capex program telegraphed.
Risks the call surfaced
Commodity inflation
HighTea inflation 7-10% currently vs prior 'benign' expectation. Salt, spices, dry fruits, cold-pressed oils all seeing cost pressure. Timing mismatch between cost hits and price realization compresses margins.
Growth normalization
MediumGrowth businesses at 47% growth (Sampann +58%) implies high base for next year. Guidance for 25-30% medium-term suggests management expects normalization. If execution lags, significant compression possible.
Starbucks maturation
MediumQ1 11% growth came off a soft prior year base (Operation Sindoor closures May). Management guides high single digit going forward. Risk of 6-8% growth vs prior market expectations of 10%+.
Capital Foods execution
MediumCapital Foods/Organic India inflection just starting (green shoots visible). Go-to-market restructured Feb 2026, still filling distributor/DSR vacancies. Risk of slower scaling if execution falters.
Tea procurement/supply
MediumPeak cropping season just starting. If El Niño continues to impact monsoon, crop quality/yield could be affected. Pricing power exists but lagged realization creates margin gap.
Management
Score 7/10. Transparent on commodity inflation and margin headwinds. Specific on segment drivers and strategic priorities. Stopped Nielsen disclosure but explained channel mix shift. Long-winded at times; could be more concise. Delivered on double-digit revenue growth and 50-75 bps margin expansion guidance. Growth businesses on track for 30% normalized guidance. Capital Foods/Organic India showing early turnaround evidence. No missed guidance reported.
1 · Q2 FY27
Tea pricing strategy clarity; new product launches across RTD, Capital Foods
2 · H2 FY27
Capital Foods/Organic India margin inflection; operating leverage kicking in
3 · FY27
Starbucks new store openings and same-store sales growth; water business capacity additions
No upside surprise to justify buy; execution risk on growth normalization.
Delivered on Plan: Growth Scaling, But Tea Inflation Tests Margin Guidance
Management hit double-digit revenue and margin expansion targets, but tea inflation jumped 7–10% versus prior 'benign' guidance. A timing lag between cost hits and price realization compressed margins sequentially—the real test is Q2 normalization.
₹427.2 Cr
+28.8% YoY
13.5%
+70 bps YoY; −100 bps QoQ
On track
50–75 bps FY27 margin expansion delivered at high end
The Guidance Story and the Inflation Reality
On the surface, Tata Consumer delivered: double-digit revenue growth, margin expansion at the high end of guidance, and a credible inflection in growth businesses. But the earnings call revealed a deeper tension—one that the post-result price action (a +1.78% day-1 pop that faded to a −0.45% loss by day 5) suggests the market is still pricing in. Prior guidance promised 'benign tea costs'; Q1 delivered 7–10% inflation. Prior quarters assumed sequential margin build; Q1 showed compression.
Tea inflation is the crux. At ₹1,200 Cr of India tea revenue, a 7–10% cost increase is material—entirely absent from prior guidance. Management took price increases in June (staggered, to manage demand), but the timing mismatch (costs hit for the full quarter, prices taken late June onwards) compressed Q1 margins by roughly 25 basis points sequentially, even as year-on-year expansion delivered 70 basis points. That math only works if pricing normalizes Q2 onwards or inflation peaks. Management is hedging both—'wait and watch 15–30 days,' Sunil D'Souza said on the call, a prudent stance given commodity volatility, but one that leaves margin visibility for the year in fog.
We're seeing about 7% to 10% inflation…the peak cropping season has just started. Minor price increases taken in June, will take judicious pricing to maintain margins.
Consolidated revenue grew 12%
Supported₹5,348.9 Cr, +11.9% YoY (management rounding)
PAT up 29%
Supported₹427.2 Cr, +28.8% YoY (rounding)
EBITDA margin expanded 70 bps, 50–75 bps guidance on track
Supported13.5% vs 12.8% prior year = +70 bps YoY; reaffirmed for FY27
Growth businesses at 47% growth, 25–30% medium-term norm credible
Supported₹1,300 Cr revenue, +47% YoY, now 36% of India business; management executing on plan
Prior guidance: 'benign tea costs'
ContradictedQ1 saw 7–10% inflation; management now hedging forecast on peak cropping
What Changed: Growth Business Inflection Is Real—Margin Risk Is New
Growth businesses have scaled to ₹1,300 Cr quarterly revenue (36% of India business), growing 47% year-on-year. Sampann (pulses, spices, dry fruits) is now a credible ₹600+ Cr run-rate business with margins recovered to 12% (from −5% in 2020). Capital Foods and Organic India, acquired for turnarounds, are showing early inflection (combined 35% growth this quarter). RTD (ready-to-drink, including Tata Water Plus) hit 41% revenue growth on 38% volume expansion. This portfolio shift—higher-margin, fast-growing adjacencies—is exactly the strategy management telegraphed, and it's delivering.
But commodity inflation now visible (not just tea: salt, spices, dry fruits, oils all seeing pressure) is a new headwind management didn't factor into prior guidance. Resolution hinges on pricing power. Salt absorbs increases more easily than tea (where 'passing costs to consumers' this quarter shrunk revenue −4% despite +2% volume growth, a clear trade-off). The risk: if inflation persists beyond the 7–10% current forecast, or if pricing lags, margin expansion falters and the 50–70 basis points full-year target comes under pressure.
How the Street Is Positioned
Price is down 15.56% from its all-time high of ₹1,282.7, now at ₹1,083.1—below its 20-, 50-, and 200-day moving averages (₹1,096.85, ₹1,117.21, ₹1,140.96). RSI at 44.7 signals neutral momentum. The post-result reaction was telling: a +1.78% day-1 pop (relief that guidance held) faded to −0.45% by day 5. Institutional flows underscore ambivalence: FII ownership fell 40 basis points sequentially to 20.79% (foreign trimming); DII ownership rose 72 basis points to 24.19% (domestic accumulation). Promoters steady at 33.83%. Volume normal—rebalancing, not panic. The market's verdict: guided execution, not upside surprise. Well-run, but fairly valued after the 15% drawdown.
Double-digit revenue growth maintained on diversified drivers
Margin expansion 70 bps YoY, at high end of 50–75 bps guidance
Growth businesses now 36% of India revenue, growing 47% YoY
Sampann margin recovery (now 12%, up from −5% in 2020) is credible
Pricing power evident in salt, coffee, and managed increases
Tea inflation 7–10% vs. prior 'benign' guidance contradicts prior assumptions
Sequential margin compression (13.5% vs 14.5% Q4) despite YoY expansion
Growth business normalization risk (47% → 25–30% medium-term target)
Starbucks growth moderating (high single digit guidance vs. prior trajectory)
Capital Foods/Organic India recovery still in early stage; go-to-market restructure incomplete
Commodity inflation persists beyond 7–10% baseline
HighEmbedded in FY27 guidance; if it worsens or persists, pricing lags again (as seen Q1: ~25 bps margin compression). Real impact: 10–15 bps margin hit per 1% tea inflation not absorbed. Full-year 50–70 bps target at risk.
Growth business normalization steeper than 25–30% plan
MediumCurrent 47% growth implies tough comps next year. If normalized growth undershoots to 15–20%, blended revenue growth halves and margin mix benefit weakens. Material headwind to consensus estimates.
Starbucks same-store sales decelerate or new openings slow
MediumStarbucks is now ~₹700 Cr quarterly (~13% of India revenue). Growth moderating from 15%+ to high single digit reduces momentum. Signals premium anchor positioning may be maturing faster than expected.
Capital Foods/Organic India inflection stalls after early green shoots
MediumCombined 35% growth this quarter, but go-to-market restructure (Feb 2026) still filling vacancies. If execution falters or distributor ramp slows, 25–30% medium-term target at risk and ₹350 Cr run-rate doesn't scale as planned.
Pricing action fails to normalize margins Q2 onwards
MediumIf tea inflation persists AND pricing lags (as in Q1), sequential margin compression continues. Sequential decline Q1→Q2→Q3 despite YoY expansion could force guidance lower—a credibility hit.
1 · August commodity trends and peak cropping clarity
Management said 'wait and watch 15–30 days' from call date. If tea inflation moderates or stabilizes at 5–7%, pricing actions taken in June normalize margins Q2. If it stays 7–10% or worsens, margin pressure persists and full-year guidance tightens.
2 · Q2 sequential margin recovery (should reach 13.8–14.2%)
Q1 showed 13.5%; full pricing flow-through from June increases should lift margins 40–70 bps sequentially. Failure to recover signals pricing lags are structural, not timing-driven.
3 · Growth business trajectory stabilization (Sampann, RTD, Capital Foods)
47% growth this quarter is cycle-high. Q2 comps toughen materially. If growth normalizes to 35–40% range next quarter, credibility to 25–30% medium-term guidance rises. If it drops below 25%, inflection narrative cracks.
Tata Consumer is executing a guided plan on a structurally sound strategy: mix shift to higher-margin growth businesses, leverage of scale in established categories (tea, salt), pricing discipline. This quarter did not surprise—it confirmed. Growth businesses are scaling faster than feared (47% growth), and margin recovery (Sampann from −5% to 12%) is tangible. But commodity inflation (particularly tea, where 7–10% costs now visible versus prior 'benign' guidance) has compressed near-term margins despite strong year-on-year expansion.
The test ahead is not the strategy—it's the pace. Can management maintain 50–70 basis points margin expansion for FY27 if commodity inflation persists? Can growth businesses sustain 25–30% normalized growth as bases toughen? Can Starbucks new openings offset single-digit same-store sales moderation? If all three hold, 17–20% medium-term EBITDA margin is credible, and the stock is undervalued post-15% drawdown. If any slip, the momentum story (which ended this quarter) doesn't resume for 2–3 years.
Verdict: Hold. Not a buy on this quarter's print alone, but not a sell on execution either. Watch tea pricing and commodity trends in August—that's the clarity inflection point for full-year margin visibility. Track sequential margin recovery in Q2 (should reach 13.8–14.2%); failure signals structural pricing lags, not timing. The honest number to track from here is organic PAT, not reported, and the pace of growth business normalization into full-year guidance.